Barclays »

Tscan Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $35k 19k 1.82
2025-06-30 $31k 21k 1.46
2025-03-31 $86k 62k 1.39
2024-12-31 $206k 68k 3.05
2024-09-30 $289k 58k 4.98
2024-06-30 $77k 13k 5.85
2022-03-31 $445k 159k 2.80